Lannett Co. Inc. | Income Statement

Fiscal year is July-June. All values USD Thousands.
2014
2015
2016
2017
2018
Sales/Revenue
273,771.00
406,837.00
566,091.00
637,341.00
684,563.00
Cost of Goods Sold (COGS) incl. D&A
99,263.00
100,481.00
256,000.00
332,128.00
395,857.00
Gross Income
174,508.00
306,356.00
310,091.00
305,213.00
288,706.00
SG&A Expense
66,319.00
75,869.00
113,379.00
115,550.00
111,392.00
EBIT
108,189.00
230,487.00
196,712.00
189,663.00
177,314.00
Unusual Expense
18,193.00
5,100.00
69,014.00
104,181.00
32,104.00
Non Operating Income/Expense
141.00
1,817.00
50.00
720.00
13,236.00
Interest Expense
130.00
207.00
65,937.00
89,420.00
85,634.00
Pretax Income
90,020.00
227,422.00
62,179.00
550.00
51,093.00
Income Tax
32,857.00
77,430.00
17,322.00
1,097.00
22,403.00
Consolidated Net Income
57,163.00
149,992.00
44,857.00
547.00
28,690.00
Net Income
57,101.00
149,919.00
44,782.00
581.00
28,690.00
Net Income After Extraordinaries
57,101.00
149,919.00
44,782.00
581.00
28,690.00
Net Income Available to Common
57,101.00
149,919.00
44,782.00
581.00
28,690.00
EPS (Basic)
1.62
4.04
1.20
0.02
0.75
Basic Shares Outstanding
33,663.60
35,827.20
36,442.80
36,812.50
37,127.30
EPS (Diluted)
1.62
4.04
1.20
0.02
0.75
Diluted Shares Outstanding
35,193.40
37,127.10
37,389.40
36,812.50
38,162.50
EBITDA
114,173.00
236,070.00
230,145.00
245,063.00
232,429.00
Non-Operating Interest Income
295.00
425.00
368.00
3,768.00
4,753.00
Minority Interest Expense
62.00
73.00
75.00
34.00
-

About Lannett Co.

View Profile
Address
9000 State Road
Philadelphia Pennsylvania 19136
United States
Employees -
Website http://www.lannett.com
Updated 07/08/2019
Lannett Co., Inc. engages in the development, manufacture, market, and distribution of generic pharmaceutical products. Its products include aqueous vitamin D 4; escltalopram oxalate; renitidine syrup; danazol; primidone; and isonlazid. The company was founded in 1942 and is headquartered in Philadelphia, PA.